贵州医科大学学报

1997, (04)

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Archive) | 高级检索(Advanced Search)

82例喉癌放疗远期效果分析
The Analysis on 82 Case of Long-term Curative Effect of Laryngocarcinoma Radiotherapy

吴伟莉,金风
Wu Weili;et alDepartment of Cancer;

摘要(Abstract):

对82例喉癌患者治疗进行分析。5、10年生存率为41.5%及25.0%,生存率与病变部位、期别、颈淋巴结转移等有关。早期声门区癌单纯放疗的疗效不亚于手术,Ⅰ期喉癌单纯放疗与手术加放疗的疗效相近,应以放疗为主;Ⅱ期喉癌单纯放疗及手术加放疗5年生存率为69.2%及100%(P<0.05),应选手术加放疗;Ⅲ、Ⅳ期喉癌单纯放疗及手术加放疗5年生存率为25%及22.7%(P>0.05),主张放疗。有颈淋巴结转移及无转移时5年生存率为22.0%及61.0%(P<0.01)。声门区癌5、10年生存率为59.4%及44.4%,声门上区癌为30.0%及12.0%,声门下区癌为33.3%及0,声门区癌较声门上、下区癌生存率高(P<0.05)。
82 patients with laryngeal carcinoma were treated at our department.The fiveyear survival rates and tenyear rates were 415% and 250%.The prognostic factors influencing survival were tumor location,stage and lymthnode involvement.The curative effect of early fottic cancer's single radiotherapy are better than opertion's,the curative effect of onestage laryngocarcinma's single radiotherapy was as the same as it of operation mixed with radiotherapy,priority should be given to radiotherape,the fiveyear survival rates of curative effect of twostage laryngocarcinoma's single radiotherapy and operation mixed with radiotherapy's were 692% and 1000% (P<005),choosing operation mixed with radiotherapy would be better,the fiveyear survival rates of curative effect of three,fourstage laryngocarcinoma's single radiotherapy and operation mixed with radiotherapy were 250% and 227% (P>005),priority should be given to radiotherapy.The fiveyear survival rates of lymthnode involvement and not involvement were 220% and 610% (P<001).The fiveyear and tenyear survival rates of glottic cancer were 574% and 444%,the supraglottic cancer's were 300% and 120%,the infraglottic cancer's were 333% and the survival rates of glottic cancer are higher than supraglottic cancer's and infraglottic cancer's (P<005).

关键词(KeyWords): 喉癌,放射疗法,手术
laryngocarcinoma;radiotherapy;operation

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 吴伟莉,金风
Wu Weili;et alDepartment of Cancer;

DOI: 10.19367/j.cnki.1000-2707.1997.04.019

文章评论(Comment):

序号(No.) 时间(Time) 反馈人(User) 邮箱(Email) 标题(Title) 内容(Content)
反馈人(User) 邮箱地址(Email)
反馈标题(Title)
反馈内容(Content)
扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享